NIH SCIENTIST PLEADS GUILTY TO CONFLICT OF INTEREST
A senior US government scientist has pleaded guilty to failing to disclose US$285,000 in payments from the drug company Pfizer. Dr Trey Sunderland of the National Institutes of Health, an expert in geriatric psychiatry, received the money for consulting work on Alzheimer’s disease. He had negotiated two five-year contracts with Pfizer without seeking approval and without disclosing it, as required by Federal law.
The maximum penalty for violating conflict-of-interest rules is a year in prison and a US$100,000 fine. Dr Sunderland will probably be told to forfeit what he received. Prosecutors are seeking a two-year suspended sentence. Congressmen are asking why he still has not been fired from his position with the NIH.
No one has been prosecuted for conflict of interest since the early 1990s. Recently, new restrictions on consulting have been introduced by the NIH. Many scientists complain that these are so harsh that they may leave the agency. The regulations bar employees from working for, or owning shares in, drug companies.
- How long can you put off seeing the doctor because of lockdowns? - December 3, 2021
- House of Lords debates assisted suicide—again - October 28, 2021
- Spanish government tries to restrict conscientious objection - October 28, 2021
Mortality rates for American kids are rising for the first time in 50 years
US President Joe Biden is so concerned about the future of American children that he inserted a mandate for affordable...
Will Pope Francis be composted?
Will Pope Francis be composted instead of buried in St Peter’s Basilica in Rome with his predecessors? It’s unlikely. But...
The virtues and the vices of the outrageous
A Norwegian bioethicist, Anna Smajdor, recently set out a case for “Whole Body Gestational Donation” – using the wombs of...
More than 200 people have been treated with experimental CRISPR therapies
Scientists believe that CRISPR gene editing technologies will transform medicine. But how many people have been treated so far? According...
Asia-Pacific IVF market could reach US$46 billion by 2031
According to a market survey by Allied Market Research, IVF is booming in the Asia-Pacific region. The market size was...
Third global summit on human genome editing: Moving on after the He experiment
The much anticipated Third International Summit on Human Genome Editing was held in London earlier this month to explore the...